22 reports

  • ASTRAZENECA IN GLOBAL MYOCARDIAL INFARCTION DRUGS MARKET
  • Vendor landscape

You can easily book an appointment with one online.

  • Heart Attack
  • AstraZeneca PLC
  • Novartis AG
  • NSTEMI group
  • Pfizer Inc.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation
  • HIGH RISKS OF INCREASED MORBIDITY, RECURRENT HOSPITALIZATIONS, AND INFLAMMATORY COMPLICATIONS, INCLUDING GASTROINTESTINAL BLEEDING, ASSOCIATED WITH THESE DEVICES.
  • MYOCARDIAL INFARCTION - DORMANT PROJECTS, H2 2018 (CONTD..3), H2 2018

Myocardial Infarction - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction - Pipeline Review, H2 2018, provides an overview of the Myocardial Infarction (Cardiovascular) pipeline landscape. Myocardial infarction...

  • Cardiovascular Disease
  • Heart Attack
  • United States
  • Company
  • Product Initiative

## ## ## ## ## ## Pfizer Inc Stealth BioTherapeutics Inc Prolong Pharmaceuticals LLC ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Minapharm Pharmaceuticals & Chemical Industries ## ## ## ## ## ## ## Merck & Co Inc ## ##

  • Clinical Trial
  • Drug Discovery And Development
  • Heart Attack
  • World
  • Product Initiative

One unit is one oximeter sensor.

  • Respiratory Monitoring
  • Sensor
  • United States
  • Company
  • GlobalData's company

ONE UNIT REFERS TO ONE PEAK FLOW METER.

  • Respiratory Monitoring
  • Germany
  • Southern Europe
  • Western Europe
  • Medtronic, Inc.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiology
  • Clinical Trial
  • Heart Attack
  • Hospital
  • World
  • Respiratory Measurement Devices Companies and Product Overview

One unit is one Capnograph.

  • Clinical Trial
  • Drug Discovery And Development
  • Hospital
  • Respiratory Monitoring
  • Sensor

NO CARDIOVASCULAR-RELATED OR GASTROINTESTINAL RELATED ADVERSE REACTIONS WERE REPORTEDPOSITIVE TOP-LINE DATA FROM U. S.

  • Hospital
  • Respiratory Monitoring
  • Northern Europe
  • United Kingdom
  • GlaxoSmithKline plc
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiovascular Disease
  • Clinical Trial
  • Heart Attack
  • Hospital
  • World
  • MYOCARDIAL INFARCTION - PIPELINE BY CADILA HEALTHCARE LTD, H1 2018
  • MYOCARDIAL INFARCTION - PIPELINE BY CARDIOL THERAPEUTICS INC, H1 2018

In patients with gastrointestinal and liver disease, who have the highest mortality risk, overall response rates were ## percent and ## percent respectively.

  • Cell Therapy
  • Heart Attack
  • United States
  • World
  • Product Initiative

Parion Sciences develops ENaC blockers which are used to treat lung, mouth, nose and the gastrointestinal tract.

  • Clinical Trial
  • Drug Discovery And Development
  • Respiratory Monitoring
  • Therapy
  • United States

ONE UNIT REFERS TO ONE CSE KIT.

  • Heart Attack
  • Respiratory Device
  • Respiratory Monitoring
  • North America
  • United States

The molecules developed by Companies in Phase II and Preclinical stages are ## and ## respectively.

  • Heart Attack
  • Therapy
  • World
  • Product Initiative
  • CicloMulsion AG

ZYAN-## acts as PHD-## inhibitor.

  • Healthcare
  • Heart Attack
  • Infectious Disease
  • Vaccine
  • Cadila Healthcare Ltd
  • ULTRA-SENSITIVE PROTEIN ASSAY - CARDIAC TROPONIN I - PRODUCT DESCRIPTION

It provides tests for infections of the bloodstream, respiratory tract and gastrointestinal tract.

  • Clinical Trial
  • Diagnostics
  • Heart Attack
  • Immunochemistry Test
  • GlobalData's company

The prominent features of this report are - ##.

  • Cardiology
  • Drug Discovery And Development
  • Heart Attack
  • World
  • Product Initiative

Another variant of Passover humidifiers is the wick one.

  • Medical Ventilator
  • Respiratory Monitoring
  • World
  • Forecast
  • Teleflex Incorporated
  • Angion Biomedica Corp. - Pipeline by Indication, 2015

- Research and Development Overview Angion Biomedica Corp. has promising clinical drug candidates for ## major therapeutic areas, Cardiovascular, Central Nervous System, Gastrointestinal, Oncology, Respiratory, Immunology, Genito Urinary System And Sex Hormones and Toxicology.

  • Heart Attack
  • Therapy
  • United States
  • Product Initiative
  • Angion Biomedica Corp.
  • Clinical Trial profile. 497 Trial Title
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Heart Attack
  • Therapy
  • World

One unit is one Capnograph.

  • Clinical Trial
  • Heart Attack
  • Respiratory Monitoring
  • United States
  • Masimo Corporation